ABSTRACT
Objective To explore effects of the INSR genotype on the waist circumference reduction after a lifestyle-based obesity intervention.
Methods This was a nested study in a cluster-randomized controlled trial conducted from September 2018 to June 2019 in Beijing, China. Four schools (200 children) were randomized to the intervention group (diet and physical activity) and 4 schools (193 children) were randomized to the control group (usual practice without a focus on obesity prevention). We followed up children at 9 months (the end of the intervention) and 31 months (22 months after the intervention), and genotyped 7 independent SNPs in the INSR gene. We assessed genetic effects on changes in five waist-related indicators [waist circumference, waist-to-hip ratio (whr), waist-to-height ratio (WHtR), waist circumference adjusted by BMI (WCadjBMI), waist-to-hip ratio adjusted by BMI (WHRadjBMI)] from baseline to 9 months and from 9 months to 31 months in the intervention and control group, respectively, and compared whether genetic effects differed by group (i.e., gene-group interaction).
Results From baseline to 9 months, we found that INSR rs7508679, rs10420008, rs11883325, and rs4804416 modified the intervention effects on changes in all waist-related indicators (all P < 0.05). In the control group, the effect allele was associated with greater increases in waist-related indicators, whereas opposite-directional associations were observed in the intervention group. Such interactions between SNPs and group assignment were almost not observed from 9 months to 31 months.
Conclusion Our data suggested that children carrying effect alleles of rs7508679, rs10420008, rs11883325, or rs4804416 may benefit more from a lifestyle intervention for obesity prevention, but the effect appeared to be attenuated in the long term.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT03665857
Funding Statement
This work was funded by the National Natural Science Foundation of China (81903343)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Peking University Institution Review Board gave ethical approval for this work (IRB00001052-20058)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Clinical Trial Registration number NCT03665857
Funding This work was supported by the National Natural Science Foundation of China (81903343).
Competing interests None declared.
Data Availability
All data produced in the present work are contained in the manuscript
